CRISPR-Cas9 system: A new-fangled dawn in gene editing-Reference-Cited by-同舟云学术

CRISPR-Cas9 system: A new-fangled dawn in gene editing

Published:2019-09 Issue: Volume:232 Page:116636
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Gupta Darshana,Bhattacharjee Oindrila,Mandal Drishti,Sen Madhab Kumar,Dey Dhritiman,Dasgupta Adhiraj,Kazi Tawsif Ahmed,Gupta Rahul,Sinharoy Senjuti,Acharya Krishnendu,Chattopadhyay Dhrubajyoti,Ravichandiran V.,Roy Syamal,Ghosh Dipanjan^ORCID

Funder

DBT

WB-DBT

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference149 articles.

1. Genome editing. The new frontier of genome engineering with CRISPR-Cas9;Doudna;Science,2014

2. Development and applications of CRISPR-Cas9 for genome engineering;Hsu;Cell,2014

3. Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain;Kim;Proc. Natl. Acad. Sci. U. S. A.,1996

4. Site-specific cleavage of DNA-RNA hybrids by zinc finger/FokI cleavage domain fusions;Kim;Gene,1997

5. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product;Ishino;J. Bacteriol.,1987

Cited by 185 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in CRISPR-Based Therapies for Genetic Modulation in Neurodegenerative Disorders;Current Gene Therapy;2025-02

2. Delivery of CRISPR/Cas9 system by AAV as vectors for gene therapy;Gene;2024-11

3. Advancements, challenges, and future perspectives in developing feline herpesvirus 1 as a vaccine vector;Frontiers in Immunology;2024-09-12

4. Gene therapy for polygenic or complex diseases;Biomarker Research;2024-09-04

5. CRISPR-CAS9-MEDIATED EX VIVO GENE EDITING FOR INHERITED HEMATOLOGICAL DISORDERS: ADVANCEMENTS, CHALLENGES, AND CLINICAL POTENTIAL;International Journal of Pharmacy and Pharmaceutical Sciences;2024-09-01